Ali Ebrahimi, MD
Pain Medicine · Burlington, MANPI 1780976894
Payments from drug & device makers
What this record shows
This record is dominated by grants: $38,315 of the $40,564 with a category attached, or 94.5%. Medtronic accounts for 95.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $33,536 and has fallen 99.5% since, to $171 in 2025. Among pain medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $1158.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$39K
- Abbott$1K
- AbbVie$138
- GRT US Holding, Inc.$131
- Pacira Pharmaceuticals Incorporated$125
- SPR Therapeutics, Inc$116
- plus $188 from 4 others
What the payments were for
- Speaking & faculty fees$1250%
- Grants$38,31594%
- Food & beverage$2,1245%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 7 | $38,745 |
| Abbott | 17 | $1,121 |
| AbbVie | 2 | $138 |
| GRT US Holding, Inc. | 1 | $131 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| SPR Therapeutics, Inc | 1 | $116 |
| Chiesi USA, Inc. | 3 | $65 |
| Si-bone, Inc. | 1 | $52 |
| Abiomed | 1 | $39 |
| Novo Nordisk | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$33,333
- Admiral Xtreme$4,981
- KYPHON EXPRESS II KYPHOPAK TRAY$255
- Proclaim Plus SCS with FlexBurst360$165
- EON C$164
- Axium INS DRG IPG$163
- OSTEOCOOL RF ABLATION SYSTEM$140
- PROCLAIM$137
- Qutenza$131
- EXPAREL$125
- BOTOX$119
- SPRINT PNS System$116
- OCTRODE$104
How this compares
$40,564 in reported general payments places this provider in the 95th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 23 | $27,735 |
| NucyntaTapentadol Hcl | 16 | $21,513 |
| Gabapentin | 23 | $1,218 |
| Lidocaine | 17 | $1,024 |
| Celecoxib | 31 | $638 |
| Amitriptyline Hcl | 40 | $586 |
| Tramadol Hcl | 41 | $275 |
| Duloxetine Hcl | 13 | $227 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $92 |
| Oxycodone Hcl | 17 | $32 |
| Prednisone | 29 | $29 |
| Meloxicam | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Burlington
- Kameel GarasBurlington$5K
- Olusola AkenroyeBurlington$4K
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.